Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients clinical trial (NCT05825443). Contact the study team or your healthcare provider for specific answers.

Question 2

What specific chemotherapy drugs will be used in combination with camrelizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients clinical trial (NCT05825443). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients clinical trial (NCT05825443). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the possible side effects of the treatments involved?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients clinical trial (NCT05825443). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients clinical trial (NCT05825443). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients clinical trial (NCT05825443). Contact the study team or your healthcare provider for specific answers.

What this study is about